GeRmLIne+
Genetic Testing for Hereditary Cancer with HRR and MMR Analysis
Germline+ uses Next-Generation Sequencing (NGS) based Genetic Testing for Hereditary and Familial Cancers that are caused by deficient DDR (DNA Damage Repair), Mismatch Repair (MMR), and HRR (Homologous Recombination Repair) genes.
Germline+ analyzes 163 genes (as per ACMG/NCCN/ESMO/AMP/CAP/FDA recommendations) associated with increased cancer risk in different hereditary and familial cancers, including breast, ovary, uterus, prostate, gastrointestinal system, stomach, colon, rectum, small bowel & pancreas amongst other cancers.
Germline+ panel offers essential value addition to the patient by including HRR pathway genes which are predictive biomarkers for PARP inhibitor therapy.
Benefits of Germline+ Cancer Gene Panel Testing
Hereditary cancer risk assessment
Predicts cancer risk if you/your family members have a deleterious mutation.
Informed decision making
To aid in the informed treatment plan.
Disease prognostication
Impact on the overall survival rate of cancer patients.
Lifecycle cost saving
Early diagnosis reduces the cost of treatment.
Why Choose 4baseCare's Germline+ Cancer Gene Panel?
Comprehensive Analysis
Our Cancer Gene Panel thoroughly assesses clinically relevant genes, ensuring accurate and reliable results.
Advanced Technology
We utilize cutting-edge genomic sequencing technologies to deliver precise and detailed genetic information.
Expert Team
Our team of experienced genetic counselors and healthcare professionals will guide you through the testing process, answer your questions, and help you understand the implications of the results.
Confidentiality and Privacy
We adhere to strict privacy protocols and maintain the confidentiality of your genetic information.
Consult our Genetic Counselor to find the right test for you.
Kindly fill the form below to download our